Clinical trial
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
NCT01240668 is registered in ClinicalTrials.gov with Otsuka America Pharmaceutical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
- Lead sponsor
- Otsuka America Pharmaceutical
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2010
- Completion date
- August 31, 2013
- Enrollment
- 5,028 (actual)
- Sites
- 79
Conditions
As the registry lists them; a condition with its own page is linked.
euvolemic hyponatremia, hypervolemic hyponatremia